Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jun 21, 2023
TickeronGET DAILY SIGNALS

AI Trading Bot: Strong performance for A, Swing Traders in Popular Stocks

AI Trading Bot generates strong performance for A Swing Trader: Popular Stocks (TA&FA)

Artificial Intelligence (AI) is driving a revolution across numerous industries, and the world of finance has been no exception. Its capability to process vast quantities of data in seconds, making precise predictions and executing decisions, makes it an invaluable tool for traders. One of the areas where AI has made a significant impact is in the domain of swing trading. A clear testimony to this fact is the recent strong performance generated for a Swing Trader "A" via an AI Trading Bot.

The Swing Trader "A" used the AI Trading Bot to navigate through the stock market's intricacies, focusing on popular stocks that encompass both Technical Analysis (TA) and Fundamental Analysis (FA). The bot was instrumental in helping the trader analyze market trends, study investor sentiment, and understand economic indicators.

With a strong performance, the results are indeed impressive. But how did the AI Trading Bot achieve this? Well, it employed its deep learning capabilities to assess and predict price patterns and trends based on historical data and current market conditions. Moreover, the bot used TA to evaluate the stocks' strength and direction, as well as FA to assess their intrinsic value.

What's even more interesting is that these positive results have been generated just ahead of A's reported earnings date. The company is expected to report earnings on August 15, 2023. This particular timing might have influenced the AI Trading Bot's decisions and strategy, making the strong performance even more notable.

The company's forthcoming financial results may provide further opportunities for the AI Trading Bot to fine-tune its decision-making process. As the earning announcement comes closer, the AI Trading Bot could incorporate more data into its deep learning models, thus potentially leading to even more impressive results.

The use of AI in trading is an area of finance that continues to evolve rapidly. The recent success of Swing Trader "A" with the AI Trading Bot clearly illustrates how AI can generate substantial returns in stock trading. The case presents an exciting future, where AI and machine learning not only augment human decision-making in trading but also can lead to tangible gains in the complex world of the stock market.

Related Ticker: A

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


Momentum Indicator for A turns positive, indicating new upward trend

A saw its Momentum Indicator move above the 0 level on November 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In 60 of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +4.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where A advanced for three days, in 187 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

The Aroon Indicator entered an Uptrend today. In 143 of 209 cases where A Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.

Bearish Trend Analysis

The 10-day RSI Indicator for A moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 17 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 61%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 68 cases where A's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 65%.

The Moving Average Convergence Divergence Histogram (MACD) for A turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 28 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where A declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.

A broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 9 (best 1 - 100 worst), indicating outstanding price growth. A’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.692) is normal, around the industry mean (67.298). P/E Ratio (34.334) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (1.447) is also within normal values, averaging (3.473). Dividend Yield (0.006) settles around the average of (0.002) among similar stocks. P/S Ratio (5.910) is also within normal values, averaging (9.775).

The Tickeron PE Growth Rating for this company is 44 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 64 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.

Notable companies

The most notable companies in this group are IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Guardant Health (NASDAQ:GH), Adaptive Biotechnologies Corp (NASDAQ:ADPT).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 20.94B. The market cap for tickers in the group ranges from 27 to 4.39T. MKYSF holds the highest valuation in this group at 4.39T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -4%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was 35%. FLGT experienced the highest price growth at 33%, while BDSX experienced the biggest fall at -52%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -19%. For the same stocks of the Industry, the average monthly volume growth was 42% and the average quarterly volume growth was -89%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 51
Price Growth Rating: 44
SMR Rating: 78
Profit Risk Rating: 85
Seasonality Score: 23 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of measurement and monitoring instruments

Industry MedicalSpecialties

Industry
Biotechnology
Address
5301 Stevens Creek Boulevard
Phone
+1 800 227-9770
Employees
18100
Web
https://www.agilent.com
Interact to see
Advertisement
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.
XRPN fell -9.70% in early regular-session trading on Tuesday, sliding from Monday's $10.41 close to $9.40. The decline follows a November 9 SEC prospectus disclosing a committed equity facility with Cantor to sell up to 5.2 million new Class A shares at 97% of the volume-weighted average price, implying up to roughly 16.7% potential dilution.
The central target of $1,620 is the arithmetic mean of verified, current analyst price targets, rounded to a clean level; it is not a single firm's forecast or a guarantee. At a recent price of about $690 , reaching $1,620 would require a gain of roughly 135% , a very large move by any standard.
The $1.50 central target is a fallback objective drawn from public market and technical discussion, not an analyst consensus, because AquaBounty Technologies, Inc. (NASDAQ: AQB) has no credible, current sell-side price targets. With the stock near $0.95, reaching $1.50 would require roughly 58% upside, a very large move for a company that has wound down its core aquaculture operations.
NVDA fell -2.10% to $216.66 during regular trading, down from a prior close of $221.30. Primary catalyst: hotter-than-expected September CPI data reignited Fed rate-hike fears, raising borrowing costs for AI infrastructure buildouts.